Cargando…
A Rare Case of Docetaxel-Induced Hydrocephalus Presenting with Gait Disturbances Mimicking and Coexisting with Taxane-Associated Polyneuropathy: The Relevance of Differential Diagnosis, Clinical Assessment, and Response to Ventriculoperitoneal Shunt
Docetaxel constitutes a widely used chemotherapeutic agent as a first-line treatment for several neoplastic diseases. One of the most common side effects induced by this drug is polyneuropathy, which among other symptoms can cause gait disbalance. However, in exceptional cases gait disturbances coul...
Autores principales: | Serrano Sponton, Lucas Ezequiel, Januschek, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731179/ https://www.ncbi.nlm.nih.gov/pubmed/29279701 http://dx.doi.org/10.1159/000481706 |
Ejemplares similares
-
Hydrocephalus owing to ventriculoperitoneal shunt dysfunction
por: Yamaguchi, Toshimasa
Publicado: (2022) -
Parkinsonism after ventriculoperitoneal shunt for hydrocephalus
por: Zhang, Yue, et al.
Publicado: (2023) -
An experience with ventriculoperitoneal shunting at keen’s point for hydrocephalus
por: Junaid, Muhammad, et al.
Publicado: (2018) -
Normal pressure hydrocephalus treated with ventriculoperitoneal shunt
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2023) -
Failed ventriculoperitoneal shunt as treatment of infantile hydrocephalus
por: Calgaro, Serena, et al.
Publicado: (2020)